Sea4us

Sea4Us is a Portuguese biotechnology company based in Sagres, Algarve, internationally recognized for the development of innovative medicines from marine compounds. Its main highlight is Sea4Pain, a new non-opioid analgesic, developed from a marine sponge, which promises to relieve chronic pain effectively and without the side effects and addiction risks associated with morphine and other opiates.

• Sea4Pain has already completed the pre-clinical phase, demonstrating an exceptional safety profile and efficacy superior to conventional therapies, without habituation, addiction or unwanted effects on the central nervous system.

In addition to the therapeutic impact, Sea4Us values sustainability and responsible innovation, also promoting the creation of scientific employment and the development of the blue economy in the Algarve. The start of clinical trials in humans is scheduled for 2026, with the ambition to launch the drug on the international market in the coming years

Click on each icon to read the articles.

• JULY 9, 2025

Sea4Us 101: How their marine-inspired Sea4Pain drug offers hope for chronic pain patients

• NOVEMBER 21, 2025

Sea4Us: a nova farmacologia que nasce do mar de Sagres

• NOVEMBER 24, 2025

"Como a morfina, mas sem efeitos indesejados." Medicamento vem do mar para aliviar dor aguda e vai ser testado em humanos